...
首页> 外文期刊>Vaccine >Haemophilus influenzae type b carriage in Indigenous children and children attending childcare centers in the Northern Territory, Australia, spanning pre- and post-vaccine eras
【24h】

Haemophilus influenzae type b carriage in Indigenous children and children attending childcare centers in the Northern Territory, Australia, spanning pre- and post-vaccine eras

机译:跨越疫苗接种前和疫苗接种后时代的土著儿童和在澳大利亚北领地儿童保育中心就读的儿童中的b型流感嗜血杆菌携带

获取原文
获取原文并翻译 | 示例
           

摘要

This paper investigates Haemophilus influenzae type b (Hib) carriage in Indigenous children and children attending childcare centres in the Northern Territory of Australia, 1992-2005. More than 10 years after the introduction of the Hib conjugate vaccine, Hib carriage persists in Indigenous children (3.4%, 2003-2005) and children attending childcare centres (0.2%, 2004). This is the first Australian study to examine Hib carriage spanning the pre- and post-vaccination eras. Increasing carriage rates contribute to Hib disease resurgence especially in those with higher disease burdens, such as remote Indigenous Australians, ongoing carriage surveillance provides a sentinel warning system for invasive disease.Background: Following the introduction of H. influenzae type b (Hib) conjugate vaccine to Australia in 1993 as a three dose (2, 4, 12 month) schedule, the incidence of Hib disease decreased dramatically in children, especially in those aged under 5 years. We investigate Hib carriage in Indigenous children and children attending childcare centres from the Northern Territory (NT) of Australia between 1992 and 2005. We report Hib carriage rates in this well vaccinated population, with previously documented high rates of invasive disease.Methods: Hib carriage was reviewed in nasopharyngeal or nasal swabs collected between 1992 and 2005; from over 2000 children (61% Indigenous) aged 0-6 years enrolled in 7 otitis media or carriage surveillance studies in the NT.Results: More than 10 years after the introduction of the Hib conjugate vaccine, Hib carriage persists at low levels, but at a higher rate in Indigenous children (3.4%, 2003-2005) than children attending childcare centres (0.2%, 2004), in the NT of Australia.Conclusions: This is the first Australian study to examine Hib carriage spanning the pre- and post-vaccination eras. Ongoing carriage surveillance provides a sentinel warning system for invasive disease. This notifies public health professionals of potential invasive disease, creating early warning systems for intervention if Australian Indigenous children or children attending childcare centres are to follow current international trends associated with high rates of carriage preceding invasive disease-despite high vaccination rates. Internationally there is growing concern that increasing carriage rates are the driving force behind Hib disease resurgence especially in those with higher disease burdens, such as remote Indigenous Australians. Changes to the vaccination schedule from PRP-OMPC (PedvaxHIB (R)), to PRP-T (2, 4, 6, 12 months) from January 2010-may affect carriage and in time, invasive disease rates. This work is important for national and International comparisons as well as feeding back information to vaccine policy makers of the Hib carriage environment throughout this period
机译:本文研究了1992-2005年在澳大利亚北领地的土著儿童和上托儿所的儿童的b型流感嗜血杆菌(Hib)携带者。引入Hib结合疫苗十多年后,Hib携带仍在土著儿童(3.4%,2003-2005年)和上托儿所的儿童(0.2%,2004年)中持续存在。这是澳大利亚首次研究跨越疫苗接种前和疫苗接种后时代的Hib携带者的研究。运载率的提高有助于Hib病的复发,尤其是在疾病负担较高的人群中,例如偏远的澳大利亚土著人,持续的运输监视为侵袭性疾病提供了定点预警系统。于1993年以三剂(2、4、12、12个月)的剂量接种到澳大利亚,儿童尤其是5岁以下儿童的Hib病发病率急剧下降。我们调查了1992年至2005年之间在澳大利亚北部地区(NT)的土著儿童和就读托儿中心的儿童中的Hib携带情况。我们报告了在这一疫苗接种良好的人群中的Hib携带率,以前有记录的入侵性疾病发生率很高。对1992年至2005年收集的鼻咽或鼻拭子进行了检查;来自NT的2000多名0-6岁儿童(61%土著儿童)参加了7项中耳炎或运输监测研究。结果:在引入Hib结合疫苗后10多年,Hib的运输持续低水平,但是澳大利亚北领地土著儿童(2003-2005年)的比率(3.4%,2004年)高于在儿童保育中心就读儿童的比率(0.2%,2004年)。结论:这是澳大利亚第一项检查Hib携带者的研究。疫苗接种后时代。持续的运输监视为入侵性疾病提供了前哨警报系统。如果澳大利亚原住民儿童或进入保育中心的儿童要遵循当前的国际趋势,即尽管接种疫苗的接种率很高,但在侵入性疾病发生之前,携带率高,这会通知公共卫生专业人员潜在的侵入性疾病,并建立干预措施的预警系统。在国际上,人们越来越担心运输速度的增加是Hib病死灰复燃的驱动力,特别是在疾病负担较高的人群中,例如偏远的澳大利亚土著人。从2010年1月起将疫苗接种时间表从PRP-OMPC(PedvaxHIB(R))更改为PRP-T(2、4、6、12个月),可能会影响运输并及时影响侵入性疾病的发生率。这项工作对于国内和国际比较以及在此期间将信息反馈给Hib携带环境的疫苗政策制定者至关重要

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号